Submit Your Abstract

Abstract submission is closed.

Guidelines

Eligibility for Publication in The Journal of Molecular Diagnostics:

An abstract that is received by the submission deadline will be considered for publication as an online supplement to the May 2018 issue of AMP’s official journal, The Journal of Molecular Diagnostics (JMD). In order to be eligible for publication in JMD, this abstract must not have been published elsewhere and may not be currently under consideration as an abstract for another meeting that occurs prior to April 2018. It must contain updated or additional data from previous publications of the subject information. Acceptance for publication is the sole decision of the AMP Europe 2018 Organizing Committee. Abstracts that have been previously published or that are under consideration as an abstract for another meeting that occurs prior to April 2018 will be rejected.
Disclosure of Financial Relationships

The AMP Europe 2018 will be an accredited educational activity. To satisfy all requirements, we have implemented a process where everyone who is in a position to influence and/or control the content of an educational activity must disclose all relevant financial relationships with any commercial interest and any conflicts of interest must be resolved prior to the educational activity. Participants of the AMP Europe 2018 must be informed of an organizer’s and/or a presenter’s (speaker, faculty, author, or contributor) academic and professional affiliation and the existence of any relevant financial relationship a presenter has with any proprietary entity producing health care goods or services consumed by, or used on patients, with the exemption of non-profit or government organizations and non-health care related companies. The intent of this disclosure is not to prevent a speaker from making a presentation. This policy allows the listener/attendee to be fully knowledgeable in evaluating the information being presented.

Disclosure includes any relationship that may bias the planning of the educational activity or may bias one’s presentation or which, if known, could give the perception of bias. These situations may include, but are not limited to: 1) stock options or bond holdings in a for-profit corporation or self-directed pension plan; 2) research grants; 3) employment (full or part-time); 4) ownership or partnership; 5) consulting fees or other remuneration; 6) non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson; 7) receipt of royalties; 8) speaker’s bureau; 9) other.

Please note that the Corresponding Author of the abstract must submit an appropriate report of potential competing interests for EACH co-author. For the purposes of submitting an abstract to the AMP Europe 2018, there should be disclosure of any aspect of the author’s personal or professional circumstances (or that of an immediate family members) that could potentially affect the author’s views on the subject that is being presented. The presence of a disclosure of a potential competing interest will not disqualify an abstract for acceptance; however, the disclosure will be noted in the Meeting Program Book, as required by guidelines. The disclosure database is built from these fields. Employees of commercial entities should disclose employment in this section. Noting the Company name in the Author Information field is not sufficient.

Abstract Content

Entry Title

Please type your Abstract Title in title case, e.g., “This Is an Example of Title Case”. You may include italics (gene names), Greek letters, and special symbols, e.g. °C (degree sign), etc. The Abstract Title is limited to no more than 200 characters.

Abstract Information

All abstracts are limited to a total of 3,000 characters (including spaces) and either one table or one chart. Your abstract must include the following information:

  1. Introduction: a brief discussion of the background or rationale of the study and/or the question addressed.
  2. Methods: the experimental approach, materials, and methods used in the study.
  3. Results: the data and results obtained in the study.
  4. Conclusions: the conclusions and/or implications of the results.